The Biotech Growth Trust (LON:BIOG) Share Price Crosses Below 50-Day Moving Average – Here’s What Happened

The Biotech Growth Trust PLC (LON:BIOGGet Free Report) crossed below its fifty day moving average during trading on Monday . The stock has a fifty day moving average of GBX 898.04 ($11.07) and traded as low as GBX 832 ($10.26). The Biotech Growth Trust shares last traded at GBX 832 ($10.26), with a volume of 27,991 shares traded.

The Biotech Growth Trust Price Performance

The company has a quick ratio of 0.00, a current ratio of 0.33 and a debt-to-equity ratio of 13.03. The firm’s 50 day simple moving average is GBX 898.04 and its 200 day simple moving average is GBX 977.63. The company has a market capitalization of £267.84 million, a PE ratio of 402.71 and a beta of 0.50.

Insiders Place Their Bets

In other The Biotech Growth Trust news, insider Nicola Shepherd bought 1,000 shares of the firm’s stock in a transaction dated Monday, January 13th. The stock was acquired at an average cost of GBX 846 ($10.43) per share, for a total transaction of £8,460 ($10,431.57). Also, insider Julie Tankard bought 1,022 shares of the firm’s stock in a transaction dated Wednesday, December 4th. The shares were acquired at an average price of GBX 972 ($11.99) per share, with a total value of £9,933.84 ($12,248.88). Insiders bought 6,222 shares of company stock valued at $5,659,584 over the last three months. 0.71% of the stock is owned by company insiders.

The Biotech Growth Trust Company Profile

(Get Free Report)

The Biotech Growth Trust seeks capital appreciation through investment in the worldwide biotechnology industry. In order to achieve its investment objective, the Company invests in a diversified portfolio of shares and related securities in biotechnology companies on a worldwide basis. Performance is measured against the NASDAQ Biotechnology Index (sterling adjusted).

Read More

Receive News & Ratings for The Biotech Growth Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Biotech Growth Trust and related companies with MarketBeat.com's FREE daily email newsletter.